{"id":880,"date":"2021-09-23T12:28:10","date_gmt":"2021-09-23T15:28:10","guid":{"rendered":"https:\/\/ondawebhost4.com.br\/vita\/en\/?post_type=noticias&p=880"},"modified":"2022-04-18T14:21:06","modified_gmt":"2022-04-18T17:21:06","slug":"anvisa-agency-accepted-in-international-inspection-program","status":"publish","type":"noticias","link":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/","title":{"rendered":"ANVISA \u2013 Agency accepted in international inspection program"},"content":{"rendered":"

The Brazilian Regulatory Agency (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria \u2013 ANVISA) was accepted in the International Program for the Rationalization of Inspections of Good Manufacturing Practices (GMP) of Active Pharmaceutical Ingredients (API), called API Cluster.<\/p>\n

The official communication of the successful completion of the Agency’s adhesion to the Program was published by European Medicines Agency (EMA) on September 17th, 2021.<\/p>\n

With this, Brazil becomes part of a group formed by several countries that work in an articulated way to perform inspections and share information.<\/p>\n

In addition to Brazil, the following authorities are also part of the program:<\/p>\n

France (National Agency for Medicines and Health Products Safety \u2013 ANSM)<\/p>\n

Denmark (The Danish Medicines Agency \u2013 DKMA)<\/p>\n

Ireland (Health Products Regulatory Authority \u2013 HPRA)<\/p>\n

Italy (Italian Medicines Agency \u2013 AIFA)<\/p>\n

United Kingdom (Medicines & Healthcare Products Regulatory Agency \u2013 MHRA)<\/p>\n

European Union (The European Directorate of the Quality of Medicines and Healthcare\u202f- EDQM)<\/p>\n

United States of America (Food and Drug Administration \u2013 FDA)<\/p>\n

Australia(Therapeutic Goods Administration \u2013 TGA)<\/p>\n

Canada (Health Canada)<\/p>\n

Japan (Pharmaceuticals and Medical Devices Agency \u2013 PMDA)<\/p>\n

World Health Organization (WHO).<\/p>\n

The entry of the ANVISA into the program reinforces all the actions of international regulatory convergence that the agency has been pursuing over the years. It is important to mention that ANVISA has been recently admitted to the Pharmaceutical Inspection Co-operation Scheme (PIC\/S).<\/p>\n

Access the full news through the link: https:\/\/bit.ly\/2XJdAjo<\/p>\n

Follow with Vita the news from the Health Authorities in Latin America and Europe.<\/p>\n","protected":false},"author":1,"featured_media":883,"template":"","meta":{"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categorias":[22],"yoast_head":"\nANVISA \u2013 Agency accepted in international inspection program - Vita<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANVISA \u2013 Agency accepted in international inspection program - Vita\" \/>\n<meta property=\"og:description\" content=\"The Brazilian Regulatory Agency (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria \u2013 ANVISA) was accepted in the International Program for the Rationalization of Inspections of Good Manufacturing Practices (GMP) of Active Pharmaceutical Ingredients (API), called API Cluster. The official communication of the successful completion of the Agency’s adhesion to the Program was published by European Medicines Agency... Leia mais »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-18T17:21:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2022\/03\/Imagem-72.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/\",\"name\":\"ANVISA \u2013 Agency accepted in international inspection program - Vita\",\"isPartOf\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\"},\"datePublished\":\"2021-09-23T15:28:10+00:00\",\"dateModified\":\"2022-04-18T17:21:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANVISA \u2013 Agency accepted in international inspection program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/\",\"name\":\"Vita\",\"description\":\"Regulatory affairs & consulting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANVISA \u2013 Agency accepted in international inspection program - Vita","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/","og_locale":"pt_BR","og_type":"article","og_title":"ANVISA \u2013 Agency accepted in international inspection program - Vita","og_description":"The Brazilian Regulatory Agency (Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria \u2013 ANVISA) was accepted in the International Program for the Rationalization of Inspections of Good Manufacturing Practices (GMP) of Active Pharmaceutical Ingredients (API), called API Cluster. The official communication of the successful completion of the Agency’s adhesion to the Program was published by European Medicines Agency... Leia mais »","og_url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/","og_site_name":"Vita","article_modified_time":"2022-04-18T17:21:06+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2022\/03\/Imagem-72.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/","url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/","name":"ANVISA \u2013 Agency accepted in international inspection program - Vita","isPartOf":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website"},"datePublished":"2021-09-23T15:28:10+00:00","dateModified":"2022-04-18T17:21:06+00:00","breadcrumb":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2021\/09\/23\/anvisa-agency-accepted-in-international-inspection-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/"},{"@type":"ListItem","position":2,"name":"ANVISA \u2013 Agency accepted in international inspection program"}]},{"@type":"WebSite","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website","url":"https:\/\/www.vitapharmaconsulting.com\/en\/","name":"Vita","description":"Regulatory affairs & consulting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias\/880"}],"collection":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media\/883"}],"wp:attachment":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=880"}],"wp:term":[{"taxonomy":"categorias","embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/categorias?post=880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}